Osaic Holdings’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Osaic Holdings's IRMD Position: Q2 2026 in Review
Osaic Holdings increased its iRadimed (IRMD) stake by 7.9% in Q2 2026, buying an estimated $40K and bringing the position to 5,964 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.
Osaic Holdings first reported a position in IRMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $617K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Osaic Holdings held 5,964 shares of iRadimed worth $570K as of Q2 2026.
- Osaic Holdings bought 439 iRadimed shares in Q2 2026, an estimated $40K.
- iRadimed made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3549 holding.
- Osaic Holdings first reported a position in iRadimed in Q1 2020 and has held it in 24 quarters since.
- Osaic Holdings's iRadimed position peaked at $617K in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.